|1st September 2020||David A Gonyer||20,238||Other acquisition or disposition||$1.05||$21,249.90|
|1st September 2020||Marilyn R. Carlson||20,238||Other acquisition or disposition||$1.05||$21,249.90|
|1st September 2020||Matthew J D'Onofrio||20,238||Other acquisition or disposition||$1.05||$21,249.90|
|2nd March 2020||Matthew J D'Onofrio||25,000||Grant/award etc.||$0.85||$21,250.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Evoke Pharma, Inc. develops Gimoti, with promotility and anti-emetic effects. Gimoti is for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus.